| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,114 |
12,758 |
$1.50M |
| 99199 |
Unlisted special service, procedure or report |
117,450 |
63,860 |
$729K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,326 |
8,545 |
$655K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,066 |
1,838 |
$189K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,172 |
1,873 |
$188K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,339 |
1,184 |
$137K |
| 99215 |
Prolong outpt/office vis |
921 |
849 |
$123K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,611 |
5,666 |
$121K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,981 |
2,573 |
$94K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,011 |
902 |
$83K |
| 92587 |
|
4,578 |
4,113 |
$61K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,986 |
3,414 |
$53K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,698 |
3,174 |
$26K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,992 |
1,460 |
$26K |
| D0145 |
Oral evaluation for a patient under three years of age |
811 |
698 |
$25K |
| 85018 |
|
7,051 |
6,237 |
$19K |
| 0001A |
|
347 |
244 |
$15K |
| 0002A |
|
299 |
218 |
$14K |
| 96127 |
|
3,228 |
2,804 |
$12K |
| D1206 |
Topical application of fluoride varnish |
824 |
710 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
747 |
353 |
$10K |
| 99051 |
|
353 |
293 |
$8K |
| 80061 |
Lipid panel |
492 |
432 |
$7K |
| 90474 |
|
323 |
290 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
516 |
456 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
165 |
110 |
$5K |
| 81003 |
|
1,773 |
1,617 |
$5K |
| 90651 |
|
310 |
271 |
$4K |
| 90734 |
|
290 |
256 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
374 |
331 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
31 |
29 |
$3K |
| 94010 |
|
125 |
112 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
181 |
162 |
$3K |
| 99401 |
|
75 |
55 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
870 |
781 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$2K |
| 83655 |
|
163 |
138 |
$2K |
| 90473 |
|
116 |
106 |
$2K |
| 69210 |
|
56 |
51 |
$2K |
| 90686 |
|
1,725 |
1,550 |
$2K |
| 94618 |
|
50 |
48 |
$1K |
| 90670 |
|
1,141 |
998 |
$1K |
| 99177 |
|
4,014 |
3,601 |
$861.30 |
| 99173 |
|
871 |
771 |
$860.08 |
| 90716 |
|
273 |
242 |
$497.98 |
| 90715 |
|
74 |
63 |
$434.25 |
| 94664 |
|
31 |
30 |
$345.03 |
| 90707 |
|
267 |
238 |
$284.90 |
| 90656 |
|
102 |
98 |
$211.01 |
| 90633 |
|
173 |
160 |
$99.34 |
| 90688 |
|
120 |
110 |
$92.82 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
28 |
25 |
$32.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
499 |
451 |
$9.32 |
| 90723 |
|
121 |
116 |
$0.00 |
| 90680 |
|
283 |
258 |
$0.00 |
| 90660 |
|
26 |
25 |
$0.00 |
| 96161 |
|
28 |
28 |
$0.00 |
| 90620 |
|
33 |
26 |
$0.00 |
| 90700 |
|
86 |
85 |
$0.00 |
| 90648 |
|
377 |
333 |
$0.00 |
| 90685 |
|
287 |
268 |
$0.00 |
| 91300 |
|
570 |
406 |
$0.00 |
| 90672 |
|
274 |
226 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
229 |
194 |
$0.00 |
| 90621 |
|
14 |
13 |
$0.00 |